Cargando…

COVID-19, severe asthma, and biologics

Detalles Bibliográficos
Autores principales:	García-Moguel, Ismael, Díaz Campos, Rocío, Alonso Charterina, Sergio, Fernández Rodríguez, Consuelo, Fernández Crespo, Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293849/ https://www.ncbi.nlm.nih.gov/pubmed/32553608 http://dx.doi.org/10.1016/j.anai.2020.06.012

Ejemplares similares

The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma–COPD Overlap Syndrome
por: Pérez de Llano, Luis, et al.
Publicado: (2022)

Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)
por: Martínez-Moragón, Eva, et al.
Publicado: (2021)

Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
por: López-Viña, Antolín, et al.
Publicado: (2022)

Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
por: López-Viña, Antolín, et al.
Publicado: (2023)

Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data
por: Pérez de Llano, Luis A, et al.
Publicado: (2022)

COVID-19, Eosinophils, and Biologicals for Severe Asthma
por: Lombardi, Carlo, et al.
Publicado: (2022)

COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
por: Hanon, Shane, et al.
Publicado: (2020)

Severe Asthma and Biological Therapies: Now and the Future
por: Sardon-Prado, Olaia, et al.
Publicado: (2023)

The Incidence and Severity of COVID-19 in the Liverpool Severe Asthma Population Undergoing Biologic Therapy
por: Abdullah, Yahya
Publicado: (2022)

Biological treatments for severe asthma
por: Jin, Hyun Jung
Publicado: (2020)

Biological therapy for severe asthma
por: Dragonieri, Silvano, et al.
Publicado: (2021)

Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study
por: Padilla-Galo, Alicia, et al.
Publicado: (2023)

COVID-19 Course in Allergic Asthma Patients: A Spanish Cohort Analysis
por: Habernau Mena, Alicia, et al.
Publicado: (2022)

Gender bias in clinical trials of biological agents for severe asthma: A systematic review
por: Ciudad-Gutiérrez, Pablo, et al.
Publicado: (2021)

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
por: Jackson, David J, et al.
Publicado: (2021)

Association of rhinitis with asthma prevalence and severity
por: Acevedo-Prado, Antonio, et al.
Publicado: (2022)

Severe asthma during the COVID-19 pandemic: Clinical observations
por: Haroun-Díaz, Elisa, et al.
Publicado: (2020)

Biologic Therapy and Severe Asthma in Children
por: Russo, Daniele, et al.
Publicado: (2021)

Biologics and airway remodeling in severe asthma
por: Varricchi, Gilda, et al.
Publicado: (2022)

Switching Biological Therapies in Severe Asthma
por: Scioscia, Giulia, et al.
Publicado: (2023)

The Impact Of COVID-19 In Asthma Control In Patients With Severe Asthma
por: Gomes, Margarida, et al.
Publicado: (2023)

Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak
por: Rial, Manuel Jorge, et al.
Publicado: (2021)

Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic
por: Patella, Vincenzo, et al.
Publicado: (2022)

Album de defectos en lingotes y en productos forjados y laminados/
por: Casuso Charterina, Florencio
Publicado: (1981)

COVID-19 and Severe Asthma: Reflections and Future Solutions [Letter]
por: Domínguez-Ortega, Javier, et al.
Publicado: (2022)

Molecular Targets for Biological Therapies of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2020)

Nonadherence in the era of severe asthma biologics and thermoplasty
por: Lee, Joy, et al.
Publicado: (2018)

Novel Biological Therapies for Severe Asthma Endotypes
por: Pelaia, Corrado, et al.
Publicado: (2022)

Biological Therapy of Severe Asthma and Nasal Polyps
por: Bakakos, Agamemnon, et al.
Publicado: (2022)

Severe Asthma in the Era of Biologics: Continuous Challenges
por: Schoini, Pinelopi, et al.
Publicado: (2023)

The relationship of asthma severity to COVID-19 outcomes
por: Zein, Joe G., et al.
Publicado: (2022)

Asthma Severity and COVID-19 Related Hospitalizations
por: Mambetsariev, Nurbek, et al.
Publicado: (2022)

Biologic Treatment For Asthma Decreases Incidence of COVID-19
por: Tovar, Sofia, et al.
Publicado: (2023)

The effects of the COVID-19 lockdown on severe asthma in patients taking biologic therapy and air pollution in Riyadh
por: Ayaz, Khan Mohammad, et al.
Publicado: (2021)

COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control
por: Caminati, Marco, et al.
Publicado: (2021)

Therapeutic Potential of Engineered Virus-like Particles of Parvovirus B19
por: Sánchez-Moguel, Ignacio, et al.
Publicado: (2023)

Anosmia and dysgeusia as markers of severity and prognosis in COVID-19
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2023)

COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain.
por: Estirado, Alicia Domínguez, et al.
Publicado: (2021)

Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study
por: García-Moguel, Ismael, et al.
Publicado: (2022)

Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate–severe asthma
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hq4jcpj00hkia3dfhjrti04lus